The effect of zoledronic acid on the volume of the fusion-mass in lumbar spinal fusion.
CONCLUSIONS: A single dose of zoledronic acid does not decrease the volume of the fusion-mass in patients undergoing spinal fusion with osteoporosis. Therefore, we recommend that zoledronic acid may be used after spinal fusion in osteoporotic patients.
PMID: 24340149 [PubMed - indexed for MEDLINE]
Source: Clinics in Orthopedic Surgery - Category: Orthopaedics Tags: Clin Orthop Surg Source Type: research
More News: Bone Graft | CT Scan | Disability | Lumbar Spinal Stenosis | Orthopaedics | Osteoporosis | PET Scan | Radiography | Reclast | Study | Zometa